[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.92.239.248. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1955

Long-Term Acetazoleamide (Diamox) Administration in Therapy of Glaucomas

Author Affiliations

St. Louis
From the Department of Ophthalmology, Washington University School of Medicine, and the Oscar Johnson Institute.

AMA Arch Ophthalmol. 1955;54(2):187-192. doi:10.1001/archopht.1955.00930020191004
Abstract

The lowering of intraocular pressure by the systemic administration of acetazoleamide (Diamox)1 and other carbonic anhydrase inhibitors * has stimulated rather widespread interest in the use of these agents in the therapy of the glaucomas.†

Considerable evidence has been accumulated to suggest that the mode of action of these pressure-lowering agents is a partial suppression of secretion of the aqueous humor.4 This hypothesis was based primarily upon tonographic and fluorescein-appearancetime data. Thus, acetazoleamide induced a fall in intraocular pressure without change in facility of outflow and associated with a delay in the appearance of fluorescein. Confirmatory evidence for this thesis has been obtained recently by measuring the change in rate of turnover of test substances in the eye and the alterations in the composition of the aqueous humor following acetazoleamide administration.‡ Of great theoretical significance have been the findings of inhibition of the carbonic anhydrase of the ciliary body

First Page Preview View Large
First page PDF preview
First page PDF preview
×